Bloodstream infections during the onset of necrotizing enterocolitis and their relation with the pro-inflammatory response, gut wall integrity and severity of disease in NEC

Autor: Heida, F.H., Hulscher, J.B.F., Schurink, M., van Vliet, M.J., Kooi, E.M.W., Kasper, D.C., Pones, M., Bos, A.F., Benkoe, T.M.

Publikováno v: In Journal of Pediatric Surgery November 2015 50(11):1837-1841

Vergleichende Wirksamkeit von intravesikalem BCG-TICE und BCG-Moreau bei Patienten mit nichtmuskelinvasivem Blasenkrebs

Autor: D'Andrea, D, Soria, F, Abufaraj, M, Korn, S, Pones, M, Gontero, P, Machado, AT, Waksman, R, Shariat, SF, Chade, D

Publikováno v: 45. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 20190509-20190511; Wien; DOC19oegu030 /20190408/

Einleitung: Intravesikale Instillationen mit Bacillus Calmette Guérin (BCG) ist die effektivste Form der intravesikalen Therapie für highrisk NMIBC nach TUR/B. Hierfür sind unterschiedliche BCG Stämme erhältlich, die alle vom ursprünglichen Vak

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ce1f77df23cbd853e4f0bfc39eefc4

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.

Autor: Pones M; Department of Urology, Medical University of Vienna, 1090 Vienna, Austria., D'Andrea D; Department of Urology, Medical University of Vienna, 1090 Vienna, Austria., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo 3-25-8, Japan., Abufraj M; Department of Urology, University of Jordan, Amman 11942, Jordan., Moschini M; Department of Urology, Luzerner Kantonsspital, 6000 Luzern, Switzerland., Comperat E; Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria., Shariat SF; Department of Urology, Medical University of Vienna, 1090 Vienna, Austria.; Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, Department of Urology, Medical University of Vienna, 1090 Vienna, Austria.; Institute of Urology and Reproductive Health, Imperial Moscow Sechenov First Moscow State Medical University, 119992 Moscow, Russia.; Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA.; Department of Urology, University of Texas Southwestern, Dallas, TX 5323, USA.; Karl Landsteiner Institute of Urology and Andrology, 1090 Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic.; European Association of Urology Research Foundation, 6803 Arnhem, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2021 May 20; Vol. 13 (10). Date of Electronic Publication: 2021 May 20.

Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia.

Autor: Stangl-Kremser J; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Suarez-Ibarrola R; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Andrea D; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Korn SM; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Pones M; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Kramer G; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria., Marhold M; Department for Internal Medicine I-Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Krainer M; Department for Internal Medicine I-Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Enikeev DV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Glybochko PV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Tamandl D; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria., Shariat SF; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital Vienna, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. shahrokh.shariat@meduniwien.ac.at.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Weill Cornell Medical College, New York, NY, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Motol Hospital, 2nd faculty of medicine, Charles University, Prague, Czech Republic. shahrokh.shariat@meduniwien.ac.at., Baltzer P; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2020 Jun; Vol. 23 (2), pp. 309-315. Date of Electronic Publication: 2019 Nov 19.

Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.

Autor: D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Soria F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, Turin, Italy., Abufaraj M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The 2 University of Jordan, Amman, Jordan., Pones M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Gontero P; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Molinette Hospital, Turin, Italy., Machado AT; Department of Urology, University of São Paulo Medical School and Institute of Cancer, São Paulo, Brazil., Waksman R; Department of Urology, University of São Paulo Medical School and Institute of Cancer, São Paulo, Brazil., Enikeev DV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Glybochko PV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Adonias SP; Department of Urology, University of São Paulo Medical School and Institute of Cancer, São Paulo, Brazil., Nahas WC; Department of Urology, University of São Paulo Medical School and Institute of Cancer, São Paulo, Brazil., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: shahrokh.shariat@meduniwien.ac.at., Chade DC; Department of Urology, University of São Paulo Medical School and Institute of Cancer, São Paulo, Brazil.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Feb; Vol. 18 (1), pp. 20-25.e2. Date of Electronic Publication: 2019 Nov 06.